“carbapenem-resistant-enterobacteriaceae” Archives

in
Entry Author Date Location
Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives 05/16/20 National
Xenex Adds $4.8M for Hospital Trial Program of Germ-Zapping Robots 10/09/18 Texas
Six Life Science Firms Close Q3 with an IPO, More Are on the Way 09/28/18 Boston
Entasis Therapeutics and Principia Biopharma Join the IPO Queue 08/20/18 Boston
Xenex Gets $38M From Essex Woodlands, Others for Germ-Zapping Robots 02/24/17 Texas
Page 1 of 1